Lincoln Pharmaceuticals Limited: insider trading, SAST and pledges

No insider-trading filing for this company in the last two years.

FiledAcquirerDirectionModeAcquiredSoldHolding afterPromoter
7 Jun 2024Munjal Mahendrabhai Patel
Reg29(2)
Acquisition Open Market 13,500
0.07%
— 13.37% Yes
6 Jun 2024Munjal Mahendrabhai Patel
Reg29(2)
Acquisition Open Market 35,000
0.17%
— 13.30% Yes
28 Feb 2024Patel Nishitkumar Maheshbhai alongwith PAC
Reg29(2)
Sale Open Market — 1,000
0.01%
0.76% Yes
27 Feb 2024Patel Nishitkumar Maheshbhai alongwith PAC
Reg29(2)
Sale Open Market — 1,000
0.01%
0.77% Yes
27 Feb 2024Renukaben Maheshbhai Patel alongwith PAC
Reg29(2)
Sale Open Market — 1,500
0.01%
0.49% Yes
26 Feb 2024Renuka Maheshbhai Patel alongwith PAC
Reg29(2)
Sale Open Market — 62,500
0.31%
0.50% Yes
26 Feb 2024Patel Nishitkumar Maheshbhai alongwith PAC
Reg29(2)
Sale Open Market — 26,500
0.13%
0.78% Yes
23 Feb 2024Renukaben Maheshbhai Patel
Reg29(2)
Sale Open Market — 11,353
0.06%
0.81% Yes
23 Feb 2024Anand Arvindbhai Patel alongwith PAC
Reg29(2)
Acquisition Open Market 30,000
0.15%
— 1.66% Yes
21 Feb 2024Renukaben Patel
Reg29(2)
Sale Open Market — 11,353
0.06%
0.81% Yes

Showing the most recent disclosures only. Sign in to see more, or upgrade your plan to see the full history. Sign in

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.